Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

ClinicalTrials.gov ID: NCT07357766

Public ClinicalTrials.gov record NCT07357766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 7:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Placebo-controlled Comparability Study to Compare Two Presentations of CagriSema in Participants With Overweight or Obesity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being done to find out how well a medicine called CagriSema helps people with overweight or obesity lose weight. CagriSema is still being tested in studies and is not yet available for doctors to prescribe. In this study the sponsor will compare two version of CagriSema injected by two different types of injection devices. Which treatment participants get is decided by chance using a computer program, so neither participants nor study staff will know which treatment is given. The study will last for about one year.

Study identification

NCT ID
NCT07357766
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 22, 2026 (Estimated)
Primary completion
Nov 29, 2027 (Estimated)
Completion
Jan 17, 2028 (Estimated)
Last update posted
Jul 9, 2026

2026 – 2028

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Uni of Alabama at Birmingham Birmingham Alabama 35233 —
Cahaba Research Pelham Alabama 35124 —
Advanced Investigative Medicine, Inc. Hawthorne California 90250 —
Southern Cal Clinical Research Santa Ana California 92701 —
Encompass Clinical Research_Spring Valley Spring Valley California 91978 —
Chase Medical Research LLC Waterbury Connecticut 06708 —
NextPhase Research Hollywood Florida 33024 —
Oceane 7 Medical & Research Center, Inc. Miami Florida 33144 —
ForCare Clinical Research Tampa Florida 33613 —
EBGS Clinical Research Center, LLC Snellville Georgia 30078 —
Rophe Adult & Pediatric Medicine Union City Georgia 30291 —
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404 —
PGM Research of Christie Clinic Champaign Illinois 61822 —
Arcturus HC PLC Troy Med Res Troy Michigan 48098 —
Anointed Nephrology & HTN, LLC Brookhaven Mississippi 39601 —
Palm Research Center Inc. Las Vegas Nevada 89128 —
Palm Research Center Inc. Las Vegas Nevada 89148 —
Weill Medical College of Cornell University New York New York 10021 —
Alliance for Multispecialty Research Norman Oklahoma 73069 —
Tribe Clinical Research LLC Greer South Carolina 29650 —
Walker Family Care Little River South Carolina 29566 —
Elligo Clin Res Centre Austin Texas 78704 —
University of Texas Southwestern Medical Center Dallas Texas 75390-9302 —
Forefront Med Res Inst PLLC Harlingen Texas 78550 —
TPMG Clinical Research Newport News Virginia 23606 —
Capital Clin Res Ctr,LLC Olympia Washington 98502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07357766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 9, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07357766 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →